This is a preview of subscription content, log in via an institution to check access.
Reference
Schabert VF, et al. Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population. Journal of Managed Care Pharmacy 19: 621-30, No. 8, Oct 2013. Available from: URL: http://dx.doi.org/2013(19)8:621-630[pii]
Rights and permissions
About this article
Cite this article
Etanercept less costly than other TNF-blockers in most indications. PharmacoEcon Outcomes News 689, 7 (2013). https://doi.org/10.1007/s40274-013-0794-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0794-7